-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $14

Benzinga·05/22/2026 09:59:17
Listen to the news
Mizuho analyst Joseph Catanzaro initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Outperform rating and announces Price Target of $14.